Journal of Infectious Diseases and Treatment Open Access

  • ISSN: 2472-1093
  • Journal h-index: 8
  • Journal CiteScore: 1.06
  • Journal Impact Factor: 0.77
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

ESKAPE active antibiotics avoiding resistance development

6th Edition of International Conference on Antibiotics, Antimicrobials and Resistance
October 11-12, 2018 Edinburgh, Scotland

Brice Felden

Rennes University School of Pharmacy, France

Posters & Accepted Abstracts: J Infec Dis Treat

Abstract:

Infections caused by bacteria with developed resistance to nearly all antibiotic classes are critically spreading. They represent a major cause of mortality and morbidity worldwide, and urgently require new compounds into clinical practice. Here we present cyclic pseudomimetic antibiotics bactericidal against ESKAPE human multi-resistant clinical isolates and stable in human sera. Modified, unnatural amino acids are required for stability and antibacterial activity on infected mice. These novel antibiotics trigger bacterial deformity, induce cell wall dissolution and alter membrane permeability. Two are active against methicillin- and vancomycin resistant Staphylococcus aureus on a mice sepsis model and also on a skin infection model. Upon prolonged exposure to the antibiotics in vitro and in infected mice, multiresistant S. aureus did not develop resistance. Three-dimensional structures of the lead compound with and without modified amino-acids provide structural insights on its activity.

Biography :

E-mail:

brice.felden@univ-rennes1.fr